Successful pregnancies with thiopurine- allopurinol co-therapy for inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 9, Issue 8, 2015, Pages 680-684

  Sheikh, Mohammed ^a   Nelson Piercy, Catherine ^b   Duley, John ^c   Florin, Timothy ^c   Ansari, Azhar ^a  

^a EAST SURREY HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Allopurinol; Pregnancy; Thiopurine

Indexed keywords

ALLOPURINOL; MERCAPTOPURINE; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONCEPTION; CROHN DISEASE; FEMALE; FETUS ECHOGRAPHY; FETUS OUTCOME; FETUS WEIGHT; HUMAN; INFLAMMATORY BOWEL DISEASE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TWIN PREGNANCY; TWIN TWIN TRANSFUSION SYNDROME; ULCERATIVE COLITIS; VAGINAL DELIVERY; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; EVALUATION STUDY; INFLAMMATORY BOWEL DISEASES; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADULT; ALLOPURINOL; AZATHIOPRINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84973098200     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv072     Document Type: Article

References (16)

1. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607
2. Akbari M, Shah S, Velayos FS, et al. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:15-22
3. van der Woude CJ, Kolacek S, Dotan I, et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010;4:493-510
4. Vermeire S, Carbonnel F, Coulie PG, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis. 2012;6:811-23
5. Ansari A, Patel N, Sanderson J, et al. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010;31:640-7
6. Smith MA, Blaker P, Marinaki AM, et al. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. J Crohns Colitis 2012;6:905-12
7. Fujii T, Nishimura H. Comparison of teratogenic action of substances related to purine metabolism in mouse embryos. Jpn J Pharmacol 1972;22:201-6
8. Bragonier JR, Roesky N, Carver MJ. Teratogenesis: effects of substituted purines and the influence of 4-hydroxypyrazolopyrimidine in the rat. Proc Soc Exp Biol Med 1964;116:685-8
9. Seinen ML, de Boer NK, van Hoorn ME, et al. Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient. Inflamm Bowel Dis 2013;19:E37
10. Fazal MW, Doogue MP, Leong RW, et al. Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series. BMC Gastroenterol 2013;13:172
11. Ansari A, Elliott T, Baburajan B, et al. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease. Aliment Pharmacol Ther 2008;28:734-41
12. Society for Maternal-Fetal Medicine, Simpson L. Twin-twin transfusion syndrome. Am J Obstet Gynecol 2013;208:3-18
13. National Institute for Health and Care Excellence. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guideline 107. London: NICE, 2010
14. Torrance HL, Benders MJ, Derks JB, et al. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009;124:350-7
15. Hoeltzenbein M, Stieler K, Panse M, et al. Allopurinol use during pregnancy outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for teratogenicity. PloS One 2013;8:e66637
16. Kozenko M, Grynspan D, Oluyomi-Obi T, et al. Potential teratogenic effects of allopurinol: a case report. Am J Med Genet 2011;155A:2247-52